Literature DB >> 27602925

No Difference in Overall Survival Between Hospital Volumes for Patients With Colorectal Cancer in The Netherlands.

Amanda C R K Bos1, Felice N van Erning, Marloes A G Elferink, Harm J Rutten, Martijn G H van Oijen, Johannes H W de Wilt, Valery E P P Lemmens.   

Abstract

BACKGROUND: High-volume hospitals have been associated with improved patient outcomes for tumors with a relatively low incidence that require complex surgeries, such as esophageal and pancreatic cancer. The volume-outcome association for colorectal cancer is under debate.
OBJECTIVE: This study investigated whether hospital volume for colorectal cancer is associated with surgical care characteristics and 5-year overall survival.
DESIGN: This is a population-based study.
SETTING: Data were gathered from the Netherlands Cancer Registry. Hospitals were grouped by volume for colon (<50, 50-74, 75-99, and ≥100 resections per year) and rectum (<20, 20-39, and ≥40 resections per year). PATIENTS: All of the patients with primary nonmetastatic colorectal cancer who underwent resection between 2005 and 2012 were included. MAIN OUTCOME MEASURES: Differences in surgical approach, anastomotic leakage, and postoperative 30-day mortality between hospital volumes were analyzed using χ tests and multivariable logistic regression analyses. Cox proportional hazard models were used to investigate the effect of hospital volume on overall survival.
RESULTS: This study included 61,394 patients with colorectal cancer. In 2012, 31 of the 91 hospitals performed less than 50 colon cancer resections per year, and 21 of the 90 hospitals performed less than 20 rectal cancer resections per year. No differences in anastomotic leakage rates between hospital volumes were observed. Only small differences between hospital volumes were revealed for conversion of laparoscopic to open resection (OR of less than 50 versus 100 or more resections per year = 1.25 (95% CI, 1.06-1.46)) and postoperative 30-day mortality (colon: OR of less than 50 versus 100 or more resections per year = 1.17 (95% CI, 1.02-1.35); rectum: OR of less than 20 versus 40 or more resections per year = 1.42 (95% CI, 1.09-1.84)). No differences in overall survival were found between hospital volumes. LIMITATIONS: Although we adjusted for several patient and tumour characteristics, data regarding comorbidity, surgeon volume, local recurrences, and specific postoperative complications other than anastomotic leakage were not available.
CONCLUSIONS: In the Netherlands, no differences in 5-year survival rates were revealed between hospital volumes for patients with nonmetastatic colorectal cancer.

Entities:  

Mesh:

Year:  2016        PMID: 27602925     DOI: 10.1097/DCR.0000000000000660

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  9 in total

1.  Impact of hospital volume on outcomes after emergency management of obstructive colon cancer: a nationwide study of 1957 patients.

Authors:  Mathilde Aubert; Diane Mege; Gilles Manceau; Valérie Bridoux; Zaher Lakkis; Aurélien Venara; Thibault Voron; Solafah Abdalla; Laura Beyer-Berjot; Igor Sielezneff; Charles Sabbagh; Mehdi Karoui
Journal:  Int J Colorectal Dis       Date:  2020-06-05       Impact factor: 2.571

2.  The adequacy of lymph node clearance in colon cancer surgery performed in a non-specialist centre; implications for practice.

Authors:  Patrick Higgins; Tamas Nemeth; Fadel Bennani; Waqar Khan; Iqbal Khan; Ronan Waldron; Kevin Barry
Journal:  Ir J Med Sci       Date:  2019-06-19       Impact factor: 1.568

3.  The Influence of Hospital Characteristics on Patient Survival in Surgically Managed Metastatic Disease of Bone: An Analysis of the SEER-Medicare Linked Database.

Authors:  Emma L Herbach; Bradley D McDowell; Elizabeth A Chrischilles; Benjamin J Miller
Journal:  Am J Clin Oncol       Date:  2022-07-06       Impact factor: 2.787

4.  The influence of hospital volume on long-term oncological outcome after rectal cancer surgery.

Authors:  Frederik H W Jonker; Jan A W Hagemans; Jacobus W A Burger; Cornelis Verhoef; Wernard A A Borstlap; Pieter J Tanis
Journal:  Int J Colorectal Dis       Date:  2017-09-07       Impact factor: 2.571

5.  Improved survival for extremity soft tissue sarcoma treated in high-volume facilities.

Authors:  Tyler Abarca; Yubo Gao; Varun Monga; Munir R Tanas; Mohammed M Milhem; Benjamin J Miller
Journal:  J Surg Oncol       Date:  2018-04-06       Impact factor: 3.454

6.  Can we Save the rectum by watchful waiting or TransAnal microsurgery following (chemo) Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC study)?: protocol for a multicentre, randomised feasibility study.

Authors:  Anouk J M Rombouts; Issam Al-Najami; Natalie L Abbott; Ane Appelt; Gunnar Baatrup; Simon Bach; Aneel Bhangu; Karen-Lise Garm Spindler; Richard Gray; Kelly Handley; Manjinder Kaur; Ellen Kerkhof; Camilla Jensenius Kronborg; Laura Magill; Corrie A M Marijnen; Iris D Nagtegaal; Lars Nyvang; Femke P Peters; Per Pfeiffer; Cornelis Punt; Philip Quirke; David Sebag-Montefiore; Mark Teo; Nick West; Johannes H W de Wilt
Journal:  BMJ Open       Date:  2017-12-28       Impact factor: 2.692

7.  Technical efficiency evaluation of colorectal cancer care for older patients in Dutch hospitals.

Authors:  Thea C Heil; René J F Melis; Huub A A M Maas; Barbara C van Munster; Marcel G M Olde Rikkert; Johannes H W de Wilt; Eddy M M Adang
Journal:  PLoS One       Date:  2021-12-17       Impact factor: 3.240

8.  Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer.

Authors: 
Journal:  BJS Open       Date:  2019-03-06

9.  Hospital variation in sphincter-preservation rates in rectal cancer treatment: results of a population-based study in the Netherlands.

Authors:  T Koëter; L C F de Nes; D K Wasowicz; D D E Zimmerman; R H A Verhoeven; M A Elferink; J H W de Wilt
Journal:  BJS Open       Date:  2021-07-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.